8-K: Dynatronics Reports Fiscal Year 2024 Results and Board Member Resignation
Quarterly Report
Dynatronics Corporation announced its fourth quarter and fiscal year 2024 financial results, along with the resignation of a board member.
Summary
- Dynatronics reported a net loss of $0.7 million for the fourth quarter of fiscal year 2024, with total net sales of $7.4 million and a gross profit margin of 22.9%.
- For the full fiscal year 2024, the company's net loss was $2.7 million, with total net sales of $32.5 million and a gross profit margin of 23.5%.
- The company had a net cash position of $0.5 million as of June 30, 2024, and $2.1 million was drawn on a $5.9 million working capital line of credit.
- Dynatronics plans to introduce new products, strengthen customer relationships, and improve operational efficiencies in fiscal year 2025.
- Brian M. Larkin resigned from the Board of Directors on September 24, 2024, after serving since 2015.
Sentiment
Score: 4
Explanation: The sentiment is negative due to the reported net losses and decreased sales, although there are some positive aspects such as new product plans and operational improvements. The resignation of a board member also adds a layer of uncertainty.
Positives
- The company has a working capital asset-based line of credit with $3.8 million available.
- Dynatronics is focused on introducing new products to drive revenue growth.
- The company is actively working to strengthen customer relationships and acquire new customers.
- Operational improvements are a priority, including cost reduction and supply chain optimization.
Negatives
- Dynatronics reported a net loss of $0.7 million for Q4 2024 and $2.7 million for the full fiscal year 2024.
- Net sales decreased from $8.4 million in Q4 2023 to $7.4 million in Q4 2024.
- Net sales decreased from $40.6 million in FY 2023 to $32.5 million in FY 2024.
- Gross profit margin decreased from 25.0% in FY 2023 to 23.5% in FY 2024.
Risks
- The company faces risks related to the broader economic environment, including higher costs and supply chain disruptions.
- There are uncertainties related to the execution of the company's business optimization strategy.
- The company's forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations.
Future Outlook
The company plans to introduce new products, strengthen customer relationships, and improve operational efficiencies in fiscal year 2025. They expect new product introductions to provide incremental revenue and pull-through revenue opportunities.
Management Comments
- Erin Enright, Chair of the Board of Directors, expressed appreciation for Brian Larkin's service since 2015.
- Brian Larkin stated it was an honor to serve as a Director and he will monitor the company's performance as a shareholder.
- Brian Baker, President & Chief Executive Officer, signed the report on behalf of the company.
Industry Context
Dynatronics operates in the medical device industry, specifically focusing on athletic training, physical therapy, and rehabilitation products. The company's performance is influenced by factors such as healthcare spending, market demand for rehabilitation products, and competition from other medical device manufacturers.
Comparison to Industry Standards
- Dynatronics' gross profit margin of 23.5% for fiscal year 2024 is lower than some of its competitors in the medical device industry, such as DJO Global which has reported gross profit margins in the 40-50% range.
- Companies like Patterson Companies, Inc. which also operate in the medical supply space, have reported higher net sales and profitability, indicating that Dynatronics is facing challenges in revenue generation and cost management.
- Compared to smaller, more specialized medical device companies, Dynatronics' revenue of $32.5 million is relatively modest, suggesting a need for more aggressive growth strategies.
- The net loss of $2.7 million for the year indicates that the company is not performing as well as some of its peers who are reporting profits.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Brian M. Larkin | Vacant | 2024-09-24 | Resignation |
Stakeholder Impact
- Shareholders may be concerned about the reported net losses and decreased sales.
- Employees may be affected by the company's operational changes and cost reduction initiatives.
- Customers may benefit from new product introductions and improved service levels.
- Suppliers may be impacted by the company's supply chain optimization efforts.
Next Steps
- The company will continue to introduce new products into the rehabilitation markets.
- The company will strengthen existing customer relationships.
- The company plans to acquire new customers.
- The company will focus on improving plant performance and supply chain initiatives.
Key Dates
| Date | Description |
|---|---|
| 2023-08-01 | Date the working capital asset-based line of credit was established. |
| 2024-06-30 | End of fiscal year 2024 and date of balance sheet highlights. |
| 2024-09-23 | Date of Brian M. Larkin's resignation as a director. |
| 2024-09-24 | Date of the press release announcing Q4 and FY 2024 results and Brian M. Larkin's resignation. |
Keywords
Dynatronics, financial results, net sales, gross profit, net loss, board of directors, medical devices, rehabilitation, physical therapy, athletic training
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.